Related content

Efficacy and safety of exenatide once weekly: an overview of the DURATION trials

By De Block Christophe EM   Van Gaal Luc F  

Expert Review of Endocrinology and Metabolism, Vol. 7, Iss. 6, 2012-11 ,pp. : 611-623

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with exenatide in predominantly Asian and Pacific Islander patients with type 2 diabetes

By Chokrungvaranon Nalurporn  

Endocrine Journal, Vol. 32, Iss. 3, 2007-12 ,pp. : 311-316

Humana Press, Inc

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Evolution of Exenatide as a Diabetes Therapeutic

By  

Current Diabetes Reviews, Vol. 9, Iss. 2, 2013-03 ,pp. : 161-193

Bentham Science Publishers

Access to resources Recommend Favorite

Diurnal patterns of plasma glucose in patients with type 2 diabetes receiving sulfonylurea and effectiveness of once daily lispro mix 50/50 injections

By Mashitani Tsuyoshi   Tsujii Satoru   Hayashino Yasuaki   Fujita Naotaka   Matsunaga Satoshi   Kurokawa Rie   Kuwata Hirohito   Ishii Hitoshi  

Diabetology International, Vol. 5, Iss. 1, 2014-03 ,pp. : 30-35

Springer Publishing Company

Access to resources Recommend Favorite